Different effects of valproic acid on photoreceptor loss in Rd1 and Rd10 retinal degeneration mice

Molecular Vision

Volumn 20, Issue , 2014, Pages 1527-1544

  Mitton, Kenneth P ^a   Guzman, Alvaro E ^a   Deshpande, Mrinalini ^a   Byrd, David ^a   DeLooff, Camryn ^a   Mkoyan, Kristina ^a   Zlojutro, Paul ^a   Wallace, Adrianne ^a   Metcalf, Brandon ^a   Laux, Kirsten ^a   Sotzen, Jason ^a   Tran, Trung ^a  

^a OAKLAND UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; FIBROBLAST GROWTH FACTOR 2; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; RHODOPSIN; VALPROIC ACID; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; CDNF PROTEIN, MOUSE; CONE ROD HOMEOBOX PROTEIN; ENZYME INHIBITOR; EYE PROTEIN; HOMEODOMAIN PROTEIN; MEF2C PROTEIN, MOUSE; MYOCYTE ENHANCER FACTOR 2; NERVE GROWTH FACTOR; NR2E3 PROTEIN, MOUSE; NRL PROTEIN, MOUSE; ORPHAN NUCLEAR RECEPTOR; PDE6B PROTEIN, MOUSE; PHOSPHODIESTERASE VI; PROTECTIVE AGENT; TRANSACTIVATOR PROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BDNF GENE; CNTF GENE; CONTROLLED STUDY; CRX GENE; DOSE RESPONSE; DRUG MEGADOSE; ELECTRORETINOGRAPHY; FGF2 GENE; GDNF GENE; GENE; GENE EXPRESSION; LOW DRUG DOSE; MEF2C GENE; MOUSE; NONHUMAN; NR2E3 GENE; NRL GENE; OPTICAL COHERENCE TOMOGRAPHY; PDE6B GENE; PHOTORECEPTOR; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; RETINA DEGENERATION; RHODOPSIN GENE; WILD TYPE; ANIMAL; C57BL MOUSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; PATHOLOGY; RETINA ROD; RETINAL DEGENERATION; SPECIES DIFFERENCE; TIME; TRANSGENIC MOUSE;

ANIMALS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 6; ENZYME INHIBITORS; EYE PROTEINS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HOMEODOMAIN PROTEINS; INJECTIONS, INTRAPERITONEAL; MEF2 TRANSCRIPTION FACTORS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE GROWTH FACTORS; ORPHAN NUCLEAR RECEPTORS; PROTECTIVE AGENTS; RETINAL DEGENERATION; RETINAL ROD PHOTORECEPTOR CELLS; RHODOPSIN; SPECIES SPECIFICITY; TIME FACTORS; TRANS-ACTIVATORS; VALPROIC ACID;

EID: 84908692072     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Berger W, Kloeckener-Gruissem B, Neidhardt J. The molecular basis of human retinal and vitreoretinal diseases. Prog Retin Eye Res 2010; 29:335-75. [PMID: 20362068].
2. Cideciyan AV, Jacobson SG, Beltran WA, Sumaroka A, Swider M, Iwabe S, Roman AJ, Olivares MB, Schwartz SB, Komaromy AM, Hauswirth WW, Aguirre GD. Human retinal gene therapy for leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement. Proc Natl Acad Sci USA 2013; 110:E517-25. [PMID: 23341635].
3. Azadi S, Johnson LE, Paquet-Durand F, Perez MT, Zhang Y, Ekstrom PA, van Veen T. Cntf+Bdnf treatment and neuroprotective pathways in the rd1 mouse retina. Brain Res 2007; 1129:116-29. [PMID: 17156753].
4. LaVail MM, Yasumura D, Matthes MT, Lau-Villacorta C, Unoki K, Sung CH, Steinberg RH. Protection of mouse photoreceptors by survival factors in retinal degenerations. Invest Ophthalmol Vis Sci 1998; 39:592-602. [PMID: 9501871].
5. Frasson M, Picaud S, Leveillard T, Simonutti M, Mohand-Said S, Dreyfus H, Hicks D, Sabel J. Glial cell line-derived neurotrophic factor induces histologic and functional protection of rod photoreceptors in the rd/rd mouse. Invest Ophthalmol Vis Sci 1999; 40:2724-34. [PMID: 10509671].
6. Ezzeddine ZD, Yang X, DeChiara T, Yancopoulos G, Cepko CL. Postmitotic cells fated to become rod photoreceptors can be respecified by cntf treatment of the retina. Development 1997; 124:1055-67. [PMID: 9056780].
7. Kirsch M, Schulz-Key S, Wiese A, Fuhrmann S, Hofmann H. Ciliary neurotrophic factor blocks rod photoreceptor differentiation from postmitotic precursor cells in vitro. Cell Tissue Res 1998; 291:207-16. [PMID: 9426308].
8. Kirsch M, Fuhrmann S, Wiese A, Hofmann HD. Cntf exerts opposite effects on in vitro development of rat and chick photoreceptors. Neuroreport 1996; 7:697-700. [PMID: 8733724].
9. Tao W, Wen R, Goddard MB, Sherman SD, O’Rourke PJ, Stabila PF, Bell WJ, Dean BJ, Kauper KA, Budz VA, Tsiaras WG, Acland GM, Pearce-Kelling S, Laties AM, Aguirre GD. Encapsulated cell-based delivery of Cntf reduces photore-ceptor degeneration in animal models of retinitis pigmen-tosa. Invest Ophthalmol Vis Sci 2002; 43:3292-8. [PMID: 12356837].
10. Andrieu-Soler C, Aubert-Pouessel A, Doat M, Picaud S, Halhal M, Simonutti M, Venier-Julienne MC, Benoit JP, Behar-Cohen F. Intravitreous injection of plga microspheres encapsulating gdnf promotes the survival of photoreceptors in the rd1/rd1 mouse. Mol Vis 2005; 11:1002-11. [PMID: 16319820].
11. Braiteh F, Soriano AO, Garcia-Manero G, Hong D, Johnson MM, Silva Lde P, Yang H, Alexander S, Wolff J, Kurzrock R. Phase 1 study of epigenetic modulation with 5-azacytidine and valproic acid in patients with advanced cancers. Clin Cancer Res 2008; 14:6296-301. [PMID: 18829512].
12. Issa J P, Kantarjian HM. Targeting DNA methylation. Clin Cancer Res 2009; 15:3938-46. [PMID: 19509174].
13. Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 2001; 276:36734-41. [PMID: 11473107].
14. Mitton KP, Guzman AE. Focus on molecules: 5-methylcyto-sine, a possible epigenetic link between ageing and ocular disease. Exp Eye Res 2012; 96:2-3. [PMID: 20620139].
15. Feng HL, Leng Y, Ma CH, Zhang J, Ren M, Chuang DM. Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model. Neuroscience 2008; 155:567-72. [PMID: 18640245].
16. Chuang DM, Leng Y, Marinova Z, Kim HJ, Chiu CT. Multiple roles of hdac inhibition in neurodegenerative conditions. Trends Neurosci 2009; 32:591-601. [PMID: 19775759].
17. Wu X, Chen PS, Dallas S, Wilson B, Block ML, Wang CC, Kinyamu H, Lu N, Gao X, Leng Y, Chuang DM, Zhang W, Lu RB, Hong JS. Histone deacetylase inhibitors up-regulate astrocyte Gdnf and Bdnf gene transcription and protect dopaminergic neurons. Int J Neuropsychopharmacol 2008; 11:1123-34. [PMID: 18611290].
18. Zhang ZZ, Gong YY, Shi YH, Zhang W, Qin XH, Wu XW. Valproate promotes survival of retinal ganglion cells in a rat model of optic nerve crush. Neuroscience 2012; [PMID: 22867974].
19. Liou GI, Wang M, Matragoon S. Timing of interphotoreceptor retinoid-binding protein (Irbp) gene expression and hypo-methylation in developing mouse retina. Dev Biol 1994; 161:345-56. [PMID: 8313988].
20. Peng GH, Chen S. Crx activates opsin transcription by recruiting hat-containing co-activators and promoting histone acetylation. Hum Mol Genet 2007; 16:2433-52. [PMID: 17656371].
21. Cvekl A, Mitton K P. Epigenetic regulatory mechanisms in vertebrate eye development and disease. Heredity 2010; 105:135-51. [PMID: 20179734].
22. Chen B, Cepko CL. Requirement of histone deacetylase activity for the expression of critical photoreceptor genes. BMC Dev Biol 2007; 7:78 [PMID: 17603891].
23. Clemson CM, Tzekov R, Krebs M, Checchi JM, Bigelow C, Kaushal S. Therapeutic potential of valproic acid for retinitis pigmentosa. Br J Ophthalmol 2011; [PMID: 20647559].
24. Geller AM, Hudnell HK, Vaughn BV, Messenheimer JA, Boyes WK. Epilepsy and medication effects on the pattern visual evoked potential. Doc Ophthalmol 2005; 110:121-31. [PMID: 16249963].
25. Verrotti A, Lobefalo L, Priolo T, Rapinese M, Trotta D, Morgese G, Gallenga PE, Chiarelli F. Color vision in epileptic adolescents treated with valproate and carbamazepine. Seizure 2004; 13:411-7. [PMID: 15276145].
26. Bayer AU, Thiel HJ, Zrenner E, Dichgans J, Kuehn M, Paulus W, Ried S, Schmidt D. Color vision tests for early detection of antiepileptic drug toxicity. Neurology 1997; 48:1394-7. [PMID: 9153479].
27. Goto Y, Taniwaki T, Shigematsu J, Tobimatsu S. The long-term effects of antiepileptic drugs on the visual system in rats: Electrophysiological and histopathological studies. Clin Neurophysiol 2003; 114:1395-402. [PMID: 12888021].
28. Chang B, Hawes NL, Pardue MT, German AM, Hurd RE, Davisson MT, Nusinowitz S, Rengarajan K, Boyd AP, Sidney SS, Phillips MJ, Stewart RE, Chaudhury R, Nickerson JM, Heckenlively JR, Boatright JH. Two mouse retinal degenerations caused by missense mutations in the beta-subunit of rod cGMP phosphodiesterase gene. Vision Res 2007; 47:624-33. [PMID: 17267005].
29. Hao H, Tummala P, Guzman E, Mali RS, Gregorski J, Swaroop A, Mitton K P. The transcription factor neural retina leucine zipper (Nrl) controls photoreceptor-specific expression of myocyte enhancer factor Mef2c from an alternative promoter. J Biol Chem 2011; 286:34893-902. [PMID: 21849497].
30. Gao H, Hollyfield JG. Basic fibroblast growth factor in retinal development: Differential levels of bFGF expression and content in normal and retinal degeneration (rd) mutant mice. Dev Biol 1995; 169:168-84. [PMID: 7750636].
31. Gao H, Hollyfield JG. Basic fibroblast growth factor: Increased gene expression in inherited and light-induced photore-ceptor degeneration. Exp Eye Res 1996; 62:181-9. [PMID: 8698078].
32. Bowes C, Li T, Danciger M, Baxter LC, Applebury ML, Farber DB. Retinal degeneration in the rd mouse is caused by a defect in the beta subunit of rod cGMP-phosphodiesterase. Nature 1990; 347:677-80. [PMID: 1977087].
33. Bowes C, Danciger M, Kozak CA, Farber DB. Isolation of a candidate Cdna for the gene causing retinal degeneration in the rd mouse. Proc Natl Acad Sci USA 1989; 86:9722-6. [PMID: 2481314].
34. Tummala P, Mali RS, Guzman E, Zhang X, Mitton KP. Temporal chip-on-chip of RNA-Polymerase-II to detect novel gene activation events during photoreceptor maturation. Mol Vis 2010; 16:252-71. [PMID: 20161818].
35. Yasuda S, Liang MH, Marinova Z, Yahyavi A, Chuang DM. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. Mol Psychiatry 2009; 14:51-9. [PMID: 17925795].
36. Chen PS, Peng GS, Li G, Yang S, Wu X, Wang CC, Wilson B, Lu RB, Gean PW, Chuang DM, Hong JS. Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astro-cytes. Mol Psychiatry 2006; 11:1116-25. [PMID: 16969367].
37. Oh EC, Cheng H, Hao H, Jia L, Khan NW, Swaroop A. Rod differentiation factor nrl activates the expression of nuclear receptor Nr2e3 to suppress the development of cone photore-ceptors. Brain Res 2008; 1236:16 [PMID: 18294621].
38. Oh EC, Khan N, Novelli E, Khanna H, Strettoi E, Swaroop A. Transformation of cone precursors to functional rod photore-ceptors by bzip transcription factor Nrl. Proc Natl Acad Sci USA 2007; 104:1679-84. [PMID: 17242361].
39. Mears AJ, Kondo M, Swain PK, Takada Y, Bush RA, Saunders TL, Sieving PA, Swaroop A. Nrl is required for rod photo-receptor development. Nat Genet 2001; 29:447-52. [PMID: 11694879].
40. Bessant DA, Payne AM, Mitton KP, Wang QL, Swain PK, Plant C, Bird AC, Zack DJ, Swaroop A, Bhattacharya SS. A mutation in Nrl is associated with autosomal dominant retinitis pigmentosa. Nat Genet 1999; 21:355-6. [PMID: 10192380].
41. Mitton KP, Swain PK, Chen S, Xu S, Zack DJ, Swaroop A. The leucine zipper of nrl interacts with the Crx homeodo-main. A possible mechanism of transcriptional synergy in rhodopsin regulation. J Biol Chem 2000; 275:29794-9. [PMID: 10887186].
42. Mali RS, Zhang X, Hoerauf W, Doyle D, Devitt J, Loffreda-Wren J, Mitton K P. Fiz1 is expressed during photoreceptor maturation, and synergizes with Nrl and Crx at rod-specific promoters in vitro. Exp Eye Res 2007; 84:349-60. [PMID: 17141759].
43. Rai K, Jafri IF, Chidester S, James SR, Karpf AR, Cairns BR, Jones DA. Dnmt3 and G9a cooperate for tissue-specific development in zebrafish. J Biol Chem 2010; 285:4110-21. [PMID: 19946145].
44. Itoh Y, Suzuki T, Miyata N. Isoform-selective histone deacetylase inhibitors. Curr Pharm Des 2008; 14:529-44. [PMID: 18336298].
45. Zhang Z, Qin X, Tong N, Zhao X, Gong Y, Shi Y, Wu X. Valproic acid-mediated neuroprotection in retinal ischemia injury via histone deacetylase inhibition and transcriptional activation. Exp Eye Res 2012; 94:98-108. [PMID: 22143029].
46. Wen R, Song Y, Cheng T, Matthes MT, Yasumura D, LaVail MM, Steinberg RH. Injury-induced upregulation of bFGF and Cntf mRNAs in the rat retina. J Neurosci 1995; 15:7377-85. [PMID: 7472491].
47. Walsh N, Valter K, Stone J. Cellular and subcellular patterns of expression of bFGF and Cntf in the normal and light stressed adult rat retina. Exp Eye Res 2001; 72:495-501. [PMID: 11311041].
48. Chang B, Hawes NL, Hurd RE, Davisson MT, Nusinowitz S, Heckenlively JR. Retinal degeneration mutants in the mouse. Vision Res 2002; 42:517-25. [PMID: 11853768].
49. Rex TS, Allocca M, Domenici L, Surace EM, Maguire AM, Lyubarsky A, Cellerino A, Bennett J, Auricchio A. Systemic but not intraocular epo gene transfer protects the retina from light-and genetic-induced degeneration. Molecular Gene Therapy. 2004; 10:855-61.
50. Obolensky A, Berenshtein E, Lederman M, Bulvik B, Alper-Pinus R, Yaul R, Deleon E, Chowers I, Chevion M, Banin E. Zinc-desferrioxamine attenuates retinal degeneration in the rd10 mouse model of retinitis pigmentosa. Free Radic Biol Med 2011; 51:1482-91. [PMID: 21824515].
51. Doonan F, O’Driscoll C, Kenna P, Cotter TG. Enhancing survival of photoreceptor cells in vivo using the synthetic progestin norgestrel. J Neurochem 2011; 118:915-27. [PMID: 21689103].
52. Boatright JH, Moring AG, McElroy C, Phillips MJ, Do VT, Chang B, Hawes NL, Boyd AP, Sidney SS, Stewart RE, Minear SC, Chaudhury R, Ciavatta VT, Rodrigues CM, Steer CJ, Nickerson JM, Pardue MT. Tool from ancient pharmacopoeia prevents vision loss. Mol Vis 2006; 12:1706-14. [PMID: 17213800].
53. Drack AV, Dumitrescu AV, Bhattarai S, Gratie D, Stone EM, Mullins R, Sheffield VC. TUDCA slows retinal degeneration in two different mouse models of retinitis pigmentosa and prevents obesity in Bardet-Biedl syndrome type 1 mice. Invest Ophthalmol Vis Sci 2012; 53:100-6. [PMID: 22110077].
54. Farber DB, Lolley RN. Cyclic guanosine monophosphate: Elevation in degenerating photoreceptor cells of the C3h mouse retina. Science 1974; 186:449-51. [PMID: 4369896].
55. Ozawa Y, Nakao K, Shimazaki T, Takeda J, Akira S, Ishihara K, Hirano T, Oguchi Y, Okano H. Downregulation of Stat3 activation is required for presumptive rod photoreceptor cells to differentiate in the postnatal retina. Mol Cell Neurosci 2004; 26:258-70. [PMID: 15207851].
56. Zhang SS, Liu MG, Kano A, Zhang C, Fu XY, Barnstable CJ. Stat3 activation in response to growth factors or cytokines participates in retina precursor proliferation. Exp Eye Res 2005; 81:103-15. [PMID: 15978261].
57. Wahlin KJ, Adler R, Zack DJ, Campochiaro PA. Neurotrophic signaling in normal and degenerating rodent retinas. Exp Eye Res 2001; 73:693-701. [PMID: 11747369].
58. Bhalla S, Joshi D, Bhullar S, Kasuga D, Park Y, Kay CN. Long-term follow-up for efficacy and safety of treatment of retinitis pigmentosa with valproic acid. Br J Ophthalmol 2013; 97:895-9. [PMID: 23603755].